| 000 | 01078 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250511222642.0 | ||
| 264 | 0 | _c19910809 | |
| 008 | 199108s 0 0 eng d | ||
| 022 | _a1040-8746 | ||
| 024 | 7 |
_a10.1097/00001622-199012000-00015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrenner, D E | |
| 245 | 0 | 0 |
_aAntitumor antibiotics, epipodophyllotoxins, and vinca alkaloids: clinical developments. _h[electronic resource] |
| 260 |
_bCurrent opinion in oncology _cDec 1990 |
||
| 300 |
_a1115-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 |
_aEtoposide _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aVinca Alkaloids _xtherapeutic use |
| 773 | 0 |
_tCurrent opinion in oncology _gvol. 2 _gno. 6 _gp. 1115-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00001622-199012000-00015 _zAvailable from publisher's website |
| 999 |
_c2106003 _d2106003 |
||